We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
-2.04%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$17.4B
AUM Growth
-$2.18B
Cap. Flow
-$1.39B
Cap. Flow %
-7.99%
Top 10 Hldgs %
37.61%
Holding
560
New
49
Increased
117
Reduced
231
Closed
99

Top Sells

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$135M
2
JPM icon
JPMorgan Chase
JPM
+$122M
3
MELI icon
Mercado Libre
MELI
+$115M
4
TDG icon
TransDigm Group
TDG
+$101M
5
GEHC icon
GE HealthCare
GEHC
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 36.55%
2 Healthcare 18.99%
3 Consumer Discretionary 11.24%
4 Communication Services 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WELL icon
301
Welltower
WELL
$170B
$2.44M 0.01%
29,825
BDX icon
302
Becton Dickinson
BDX
$45.6B
$2.44M 0.01%
+9,428
New +$2.55M
PFE icon
303
Pfizer
PFE
$142B
$2.42M 0.01%
73,022
SBCF icon
304
Seacoast Banking Corp of Florida
SBCF
$3.35B
$2.4M 0.01%
109,476
-3,592
-3% -$84.1K
PLD icon
305
Prologis
PLD
$136B
$2.39M 0.01%
21,262
CQP icon
306
Cheniere Energy
CQP
$31.5B
$2.37M 0.01%
43,700
BMY icon
307
Bristol-Myers Squibb
BMY
$132B
$2.33M 0.01%
40,225
SRE icon
308
Sempra
SRE
$58.6B
$2.32M 0.01%
34,042
PETQ
309
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2.28M 0.01%
115,608
-25
-0% -$447
SCCO icon
310
Southern Copper
SCCO
$145B
$2.26M 0.01%
32,321
NKE icon
311
Nike
NKE
$62.7B
$2.25M 0.01%
23,535
-273,723
-92% -$28.2M
GPN icon
312
Global Payments
GPN
$23.8B
$2.21M 0.01%
+19,188
New +$2.28M
MDT icon
313
Medtronic
MDT
$110B
$2.14M 0.01%
27,259
CAH icon
314
Cardinal Health
CAH
$53.2B
$2.12M 0.01%
24,401
-94,678
-80% -$8.56M
ED icon
315
Consolidated Edison
ED
$40.4B
$2.11M 0.01%
+24,619
New +$2.24M
MTN icon
316
Vail Resorts
MTN
$5.45B
$2.09M 0.01%
9,438
-475
-5% -$113K
PRVA icon
317
Privia Health
PRVA
$3.01B
$2.07M 0.01%
89,794
-19
-0% -$483
PLRX icon
318
Pliant Therapeutics
PLRX
$65.6M
$2.01M 0.01%
116,005
+7,862
+7% +$136K
ZTS icon
319
Zoetis
ZTS
$31.9B
$1.98M 0.01%
11,382
+6,898
+154% +$1.25M
DHI icon
320
D.R. Horton
DHI
$40.7B
$1.98M 0.01%
18,393
+17,225
+1,475% +$2.06M
PM icon
321
Philip Morris
PM
$299B
$1.97M 0.01%
21,271
GNRC icon
322
Generac Holdings
GNRC
$11.3B
$1.97M 0.01%
18,073
-1,645
-8% -$203K
STZ icon
323
Constellation Brands
STZ
$22.3B
$1.91M 0.01%
+7,616
New +$1.99M
NVS icon
324
Novartis
NVS
$301B
$1.91M 0.01%
18,758
-287
-2% -$29.1K
SYY icon
325
Sysco
SYY
$40.6B
$1.89M 0.01%
28,685
-3,431
-11% -$247K

Similar funds

Fred Alger Management's Q3 2023 Portfolio in Review

As of Q3 2023, Fred Alger Management held 560 positions worth $17.4B, down 11% from $19.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fred Alger Management withdrew a net $1.39B in Q3 2023, closing 99 positions and reducing 231 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fred Alger Management opened a new position in Extreme Networks worth $33.9M.

  • Fred Alger Management's largest Q3 2023 buy was Extreme Networks: 1,401,093 shares worth $33.9M.
  • Fred Alger Management added most to Meta Platforms (Facebook) in Q3 2023, an estimated $275M increase.
  • Fred Alger Management's biggest Q3 2023 reduction was Las Vegas Sands, cutting an estimated $135M.
  • Fred Alger Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $41.5M.
  • Fred Alger Management's ten largest holdings make up 38% of its $17.4B portfolio in Q3 2023.
  • Fred Alger Management opened 49 new positions and closed 99 in Q3 2023.
  • Fred Alger Management's portfolio value fell 11% quarter-over-quarter to $17.4B.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.